We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AFMD market cap is 79.15M. The company's latest EPS is EUR -5.7590 and P/E is -0.92.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 15.01M | 11.93M | 4.92M | 2.11M | 1.96M |
Operating Income | -34.63M | -30.11M | -31.46M | -31.76M | -38.05M |
Net Income | -16.49M | -33.44M | -31.98M | -29.4M | -24.36M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 25.25M | 21.68M | 28.99M | 41.68M | 42.77M |
Operating Income | -19.54M | -32.38M | -34.72M | -64.03M | -88.12M |
Net Income | -19.48M | -32.37M | -41.37M | -57.52M | -86M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 236.4M | 200.51M | 167.96M | 134.71M | 120.46M |
Total Liabilities | 55.3M | 47.6M | 42.87M | 35.79M | 44.04M |
Total Equity | 181.1M | 152.92M | 125.09M | 98.93M | 76.42M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 116.17M | 112.36M | 175.73M | 225.14M | 200.51M |
Total Liabilities | 76.05M | 73.69M | 103.73M | 89.18M | 47.6M |
Total Equity | 40.13M | 38.67M | 71.99M | 135.95M | 152.92M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -73.93M | -104.89M | -33.24M | -66.57M | -84.83M |
Investing | 3.48M | 5.61M | -8k | -11k | -37.47M |
Financing | 89.14M | 88.56M | -634k | -3.21M | -4.82M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 49.44M | -29.06M | -19.4M | -86.59M | -104.89M |
Investing | -15.61M | 4.34M | 8.01M | -3.85M | 5.61M |
Financing | 20.5M | 26.04M | 69.25M | 133.58M | 88.56M |
Market Cap | 79.15M |
Price to Earnings Ratio | -0.92 |
Price to Sales Ratio | 1.85 |
Price to Cash Ratio | 0.42 |
Price to Book Ratio | 0.52 |
Dividend Yield | - |
Shares Outstanding | 14.93M |
Average Volume (1 week) | 79.84k |
Average Volume (1 Month) | 516.02k |
52 Week Change | -29.31% |
52 Week High | 11.10 |
52 Week Low | 2.235 |
Spread (Intraday) | 0.04 (0.75%) |
Company Name | Affimed NV |
Address |
technologiepark im neuenheimer feld 582 heidelberg 69120 |
Website | https://www.affimed.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions